Molecular imaging & imaging-guided therapy

Preclinical and clinical imaging CERIMED platforms

Leader : Pascal BELIN (AMU, CERIMED, INT)

Methodological developments generated by the activity of DHU-Imaging teams will be validated on CERIMED (pre)clinical imaging platforms , and then implemented for hospital, academic, and industrial partners, with the support of OPTITEC and Eurobiomed clusters, to improve deliveries.

The objective of CERIMED imaging platforms is to address cutting-edge scientific issues, as well as to facilitate access to clinical trials and cohort studies. CERIMED is equipped with all (pre)clinical modalities: PET, SPECT, CT-scan, angiography (interventional procedures), US and optical imaging techniques. Moreover, CERIMED provides access to dedicated areas authorized for human and animal experimentations to validate prototypes in comparison to the reference technique.

Partners